
Bacalt Biosciences Private Limited
About Bacalt Biosciences Private Limited
Data last updated:
Bacalt Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the scientific research segment of the research and development sector. It was incorporated on 11 January 2023.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2023PTC170225.
The company has an authorised share capital of ₹10.6 Lakh and a paid-up capital of ₹1.57 Lakh. It is led by directors Shruti Ketan Kutmutia and Pranav Girijavallabhan Nair.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.21 Lakh, a growth of 111% compared to the previous year. For the same year it recorded a net loss of ₹3.34 Lakh (net margin -14.4%) and EBITDA of -₹2.89 Lakh (EBITDA margin -12.5%).
The company has 1 deal on record (1 funding round), with disclosed funding of ₹18 Cr; the latest was in September 2025.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Bacalt Biosciences
Contact details
Bacalt Biosciences Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressVv Towers Noo. 44/2 1st Floor Beratene Agrahara, Begur Hobli, Bangalore, Karnataka, India – 560100
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bacalt Biosciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Bacalt Biosciences Private Limited, buy the company report.
Financials of Bacalt Biosciences Private Limited
FY 2025 filings availableBacalt Biosciences Private Limited reported revenue of ₹23.21 Lakh (up 111% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 111% in the latest year. EBITDA fell 183% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.89 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.34 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -12.5% | ||
| Net Profit Margin | -14.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Bacalt Biosciences Private Limited, buy the company report.
Board of directors of Bacalt Biosciences Private Limited
Bacalt Biosciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shruti Ketan Kutmutia Also directs: Kutmutia Family LLP | Director | 11 Jan 2023 | 3 Years 9 Months | Current |
| Pranav Girijavallabhan Nair | Director | 21 Mar 2025 | 1 Years 7 Months | Current |
Deals & funding
Bacalt Biosciences Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹18 Cr; the latest was in September 2025.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2025 | Funding round · Pre-seed | ₹18 Cr | Investors: Avaana Capital, Lubrizol InnoVentures |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Bacalt Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bacalt Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bacalt Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bacalt Biosciences Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Mayank Ketan Kutmutia ceased to be Director on 22 Mar 2025.
Frequently asked questions
Bacalt Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in science research, within the research and development industry. It was incorporated on 11 January 2023 (3+ years old) and is registered under CIN U73100KA2023PTC170225.
Bacalt Biosciences has 2 current directors:
- Shruti Ketan Kutmutia - Director
- Pranav Girijavallabhan Nair - Director
The latest financial statements of Bacalt Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Bacalt Biosciences is U73100KA2023PTC170225. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bacalt Biosciences was incorporated on 11 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
Bacalt Biosciences has 1 deal on record (1 funding round), with disclosed funding of ₹18 Cr; the latest was in September 2025.
Mayank Ketan Kutmutia ceased to be Director on 22 Mar 2025. Pranav Girijavallabhan Nair was appointed as Director on 21 Mar 2025. Madhav Sethia ceased to be Director on 23 Nov 2024. Bacalt Biosciences has 4 board changes on record in total.
Yes, Bacalt Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Bacalt Biosciences is at Vv Towers Noo. 442 1st Floor Beratene Agrahara, Begur Hobli, Bangalore, Karnataka, India – 560100.
Bacalt Biosciences operates in the research and development industry, in the science research segment.